Toronto Stocks Higher, Fortuna Silver Mines Down on Higher Costs, Mexican Mine Forecast
By Adriano Marchese
Stocks in Toronto were modestly higher. Sector performance was mixed, with process industries, producer manufacturing and materials stocks declining the most, offset by gains in consumer durables, tech and commercial services.
Canada's S&P/TSX Composite Index was up 0.14% higher to 20724.84 on Thursday and the blue-chip S&P/TSX 60 edged 0.14% to 1250.89.
Fortuna Silver Mines shares were 14% lower at 4.15 Canadian dollars ($3.07) after the company said its mine in Mexico would be exhausted earlier than anticipated, and that it faced potential higher costs going forward.
Other market movers:
Birchcliff Energy shares fell by 9.6% to C$5.19 after the company said it expects production in 2024 to be similar to 2023, on the low end of guidance, and that it has cut its dividend.
Dye & Durham shares were lower by 3.5% at C$12.66 after the company said it intends to raise C$126 million by way of a bought deal offering of its shares to pay down debt.
Canopy Growth plans to raise $35 million by way of a private placement to strengthen its balance sheet. Shares trading in Toronto were down 3.3% to C$6.13.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 18, 2024 12:30 ET (17:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks